Clinical Trials · NCT00046137
Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 0
- Start date
- Not specified
- Locations
- 13 sites, United States
- Primary endpoint
- Study in Osteoporosis, Postmenopausal